Metrexassist (TK-90)
/ Tosk
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
January 25, 2024
A Phase 2 multi-center, placebo-controlled, randomized study to assess the safety and efficacy of parenteral TK-90 for preventing radiation-induced mucositis in patients with squamous cell carcinoma of the head and neck
(MHNCS 2024)
- "Parenteral administration of TK-90 presents a promising and effective strategy for preventing radiation-induced OM in SCCHN patients. Notably, TK-90 demonstrates good tolerability, with no Grade 3- 4 AEs reported, and does not lead to an increase in RT-associated toxicities. These optimistic results merit additional validation in an upcoming, more expansive randomized study."
Clinical • P2 data • Cardiovascular • Head and Neck Cancer • Mucositis • Oncology • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Stomatitis
August 14, 2023
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
(clinicaltrials.gov)
- P2a | N=24 | Active, not recruiting | Sponsor: Tosk, Inc. | Recruiting ➔ Active, not recruiting | Trial completion date: Jun 2023 ➔ Sep 2023 | Trial primary completion date: Mar 2023 ➔ Sep 2023
Enrollment closed • Trial completion date • Trial primary completion date • Colorectal Cancer • Gastrointestinal Cancer • Mucositis • Oncology • Solid Tumor
August 14, 2023
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690
(clinicaltrials.gov)
- P2a | N=24 | Active, not recruiting | Sponsor: Tosk, Inc. | Recruiting ➔ Active, not recruiting | Trial completion date: Jun 2023 ➔ Sep 2023 | Trial primary completion date: Mar 2023 ➔ Sep 2023
Enrollment closed • Metastases • Trial completion date • Trial primary completion date • Head and Neck Cancer • Mucositis • Oncology • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck
January 03, 2023
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
(clinicaltrials.gov)
- P2a | N=24 | Recruiting | Sponsor: Tosk, Inc.
New P2a trial • Colorectal Cancer • Gastrointestinal Cancer • Mucositis • Oncology • Solid Tumor
1 to 4
Of
4
Go to page
1